首页> 美国政府科技报告 >Prophylaxis and Treatment of Newborn Endotoxic Shock with Anti-Lipid A MonoclonalAntibodies
【24h】

Prophylaxis and Treatment of Newborn Endotoxic Shock with Anti-Lipid A MonoclonalAntibodies

机译:抗脂质a单克隆抗体预防和治疗新生儿内毒素休克

获取原文

摘要

Gram negative sepsis septic shock continues to cause high mortality in newborns.Newborn endotoxic shock has been reported to have a different pathophysiology than the adult. The immature systems in the newborn are responsible for the different patho-physiology of endotoxic shock. The complex physiology of the newborn causes difficulty of endotoxic shock treatment. Endotoxic shock is induced by lipopolysaccharide, an essential component of the outer membrane in gram-negative organisms. Therefore, immunoglobulins against lipopolysaccharides have been used for the treatment of gram-negative sepsis/septic shock.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号